Skip to main content

Table 3 Power of a future case control study at given effect sizes

From: Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

N = 30/group

Effect size

0.45

0.5

0.55

0.6

Power*

0.62

0.73

0.83

0.90

  1. * At a significance level of 0.05, after adjustment for 6 comparisons (assumed number of protein biomarkers) using the conservative Bonferroni method
Back to article page

Clinical Proteomics

ISSN: 1559-0275